HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The use of botulinum toxin in the treatment of spastic hip joint instability in children with cerebral palsy].

AbstractUNLABELLED:
Authors present the effect of intramuscular injections of botulinum toxin A (BTX-A) in the treatment of hip instability in children with spastic cerebral palsy.
MATERIAL AND METHOD:
The sixty-seven non walking children (110 hips) with quadriplegia and hip instability (MP > 33% or increase of MP > 20% in the second follow-up after 12 months) were evaluated. The mean age of patients in the beginning of study was 3 years and 8 months (SD = 2 years). The patients were randomly allocated to administrations of BTX-A - group A (52 hips) or to observation - group B (58 hips). The intramuscular injections of BTX-A were performed every 3 months, bilaterally to adductors, medial hamstrings and psoas muscles. The choice of muscles for BTX-A administration was determined by the results of clinical examination consisting in dynamic assessment of joint range of motion. The groups of muscles presenting the dynamic contraction (3 and more in Ashworth Scale) were injected. The a-p radiographs were used to assess the migration percentage (MP). The average length of follow-up was 21 months.
RESULTS:
The mean value of MP in the group A was 38% at the beginning of treatment and 28% at the end of follow-up (difference statistically significant; p < 0.00001). The mean value of MP in the group B was 36% at the primary examination and 38% at the final examination (difference statistically significant; p < 0.00001). The mean progression (-) for the group A = 10% (improvement) and for the group B +3% (deterioration) (difference statistically significant; p < 0.00001).
CONCLUSIONS:
Locate specific target intramuscular injections of botulinum toxin A (BTX-A) are a useful method of prevention of the neurogenic hip dislocation in children with spastic cerebral palsy.
AuthorsMarek Jóźwiak, Piotr Harasymczuk, Kinga Ciemniewska-Gorzela
JournalChirurgia narzadow ruchu i ortopedia polska (Chir Narzadow Ruchu Ortop Pol) 2007 May-Jun Vol. 72 Issue 3 Pg. 205-9 Poland
Vernacular TitleZastosowanie toksyny botulinowej typu A w leczeniu neurogennego podwichniecia stawów biodrowych u dzieci z tetraplegia spastyczna w przebiegu mózgowego porazenia.
PMID17941584 (Publication Type: Controlled Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins
Topics
  • Botulinum Toxins (administration & dosage)
  • Cerebral Palsy (complications)
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Joint Instability (drug therapy, etiology)
  • Male
  • Muscle Spasticity (drug therapy, etiology)
  • Neuromuscular Agents (administration & dosage)
  • Quadriplegia (complications)
  • Range of Motion, Articular
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: